Pharmacy Practice

Continuing Competence for Pharmacists

Policy 9905

11/01/1999 Introduced
03/01/2004 Reapproved
12/01/2008 Revised
10/01/2012 Reapproved

02/13/2019 Revised

AMCP supports the collaboration of pharmacists, managed care organizations, health care systems, employers, payers, professional organizations, and legislative and regulatory bodies in the development of continuing pharmacy education and continuing professional development opportunities to improve the competence of pharmacists. Pharmacists have a corresponding responsibility to identify areas for focused education and/or experiential training and to reassess their competence in these areas.
Interchange of Narrow Therapeutic Index (NTI) Drugs

Policy 9912

11/01/1999 Introduced
03/01/2004 Reapproved
12/01/2008 Reapproved
AMCP supports the Food and Drug Administration's (FDA) position that when an FDA-approved and therapeutically equivalent generic drug is selected, patients, physicians, and pharmacists can be assured that they will see the same clinical results and safety profile as with the equivalent brand name product. Therefore, NTI drugs should not be considered as a separate category for purposes of generic substitution. AMCP believes that pharmacists, in consultation with prescribers, should have the right to use their professional judgment and knowledge of the available scientific information in determining when to substitute a generic product.

(See AMCP Managed Care Pharmacy Practice Positions - Interchange of Narrow Therapeutic Index (NTI) Drugs)

Therapeutic Purpose Inclusion on Prescriptions and Medication Orders

Policy 0027

11/01/1999 Introduced
03/01/2004 Reapproved 
12/01/2008 Reapproved
10/01/2012 Revised
03/27/2017 Reapproved
02/13/2019 Revised
10/29/2019 Revised

In order for pharmacists to fulfill their responsibility for monitoring and reviewing pharmaceutical care of the patient, AMCP encourages inclusion of the diagnosis and indication on prescriptions or medication orders to improve coordination of care and patient safety. 

Medication Use Outside of the Home

Policy 0105

03/01/2001 Introduced
02/01/2006 Revised
12/01/2010 Revised

04/07/2015 Reapproved

AMCP recognizes the role of pharmacists in improving the safe and appropriate use and storage of medications in all environments.  Institutions, such as hospitals and long-term care facilities, have regulations and requirements for administration and storage of medications.  However, many entities like schools, camp, and group homes, do not have regulations or requirements regarding the handling of medications in their facilities.  AMCP recommends that pharmacists be actively involved in the development of procedures for safe and appropriate medication use and storage by working with parents and appropriate personnel at schools, camps and group homes to improve medication use policies and procedures within their specific environment. 

Safe Medication Disposal

Policy 1803

02/21/2018 Introduced
 

 

AMCP supports the development and utilization of programs to assist in the safe disposal of unused or unwanted medications, such as in-house disposal, use of authorized collectors, and drug take-back days, to help reduce harm from unintended use, misuse, or accidental exposure.

Related